Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Rev Gastroenterol Mex (Engl Ed) ; 84(1): 69-99, 2019.
Article in English, Spanish | MEDLINE | ID: mdl-30711302

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not taken to counteract what is now considered a national health problem, the medium-term panorama will be very bleak. This serious situation prompted the Asociación Mexicana de Gastroenterología and the Asociación Mexicana de Hepatología to produce the Mexican Consensus on Fatty Liver Disease. It is an up-to-date and detailed review of the epidemiology, pathophysiology, clinical forms, diagnosis, and treatment of the disease, whose aim is to provide the Mexican physician with a useful tool for the prevention and management of nonalcoholic fatty liver disease.


Subject(s)
Non-alcoholic Fatty Liver Disease/therapy , Consensus , Disease Progression , Humans , Mexico , Non-alcoholic Fatty Liver Disease/epidemiology , Non-alcoholic Fatty Liver Disease/physiopathology , Prevalence , Risk Factors
3.
Rev Gastroenterol Mex ; 74(3): 246-8, 2009.
Article in English | MEDLINE | ID: mdl-19858016

ABSTRACT

The prevalence of inflammatory bowel disease in Mexico is low. The occurrence in familial cases has been attributed to genetic influences. We described the first report of inflammatory bowel diseases in one pairs of husband-wife in Mexico. According with characteristics of this case, we can speculate that the environmental and infectious etiology might play some role in the development of IBD.


Subject(s)
Colitis, Ulcerative/pathology , Adult , Biopsy , Colonoscopy , Crohn Disease/complications , Crohn Disease/therapy , Female , Gastroesophageal Reflux/complications , Gastroesophageal Reflux/therapy , Humans , Male , Marriage , Mexico
4.
Rev Gastroenterol Mex ; 74(4): 334-40, 2009.
Article in Spanish | MEDLINE | ID: mdl-20423763

ABSTRACT

BACKGROUND: It has been reported that pro-inflammatory cytokines levels like IL-6 and TNF-α can determine the degree of inflammation of ulcerative colitis (UC). AIMS: To measure the gene expression of IL-6 and TNF-á in patients with UC and controls and to correlate with histological activity. PATIENTS AND METHODS: We studied 36 patients with UC, 13 healthy controls and 11 with inflammation. After total ribonucleic acid (RNA) extraction, complementary deoxyribonucleic acid (DNA) was synthesized by polymerase chain reaction (PCR) and relative expression was determined through real-time PCR for IL-6 and TNF-á. Statistical analysis was performed using the Kruskal-Wallis test and Spearman correlation. RESULTS: The expression of IL-6 increases in patients with active UC compared to controls (p = 0.004) as well as UC patients in remission (p = 0.014). There was no significant difference between patients with active UC and controls with inflammation. (p = 0.446). Gene expression of TNF-α was higher in biopsies from patients with UC activity compred with control subjects (p = 0.004), as well as those in remission (p = 0.001). The expression of IL-6 correlated significantly (p = 0.02) with histological activity. CONCLUSIONS: The gene expression of IL-6 and TNF-α is increased in active UC. Interleukin 6 is better marker of bowel inflammation because its expression correlates with histological activity.


Subject(s)
Colitis, Ulcerative/genetics , Interleukin-6/metabolism , Intestinal Mucosa/metabolism , Rectum/metabolism , Tumor Necrosis Factor-alpha/metabolism , Adult , Female , Gene Expression Regulation , Humans , Male
5.
Salud Publica Mex ; 41(6): 475-8, 1999.
Article in Spanish | MEDLINE | ID: mdl-10634078

ABSTRACT

OBJECTIVE: To investigate the prevalence of the hepatitis C virus (HCV) and B virus (HBV) in blood donors attending Médica Sur Hospital. MATERIAL AND METHODS: A total of 9,099 blood donors were tested for hepatitis B and C viruses from 1994 to 1998. A questionnaire was used to collect data and HCV and HBV were detected in serum. We obtained percentages and assessed statistical significance using the chi 2 test. RESULTS: The prevalence of HCV and HBV carriers was 0.47 and 0.11 per cent. The main risk factors were dental procedures (11.6% for HCV and 20%, for HBV), and unsafe sexual practices (20%) for HBV. CONCLUSIONS: These results indicate a low prevalence of HCV and HBV infection in this population.


Subject(s)
Blood Donors/statistics & numerical data , Carrier State/epidemiology , Hepatitis B/epidemiology , Hepatitis C/epidemiology , Urban Population/statistics & numerical data , Adolescent , Adult , Aged , Cross-Sectional Studies , Female , Humans , Male , Mexico/epidemiology , Middle Aged , Prevalence , Risk Factors , Seroepidemiologic Studies
6.
Rev Invest Clin ; 49(3): 215-20, 1997.
Article in English | MEDLINE | ID: mdl-9294961

ABSTRACT

A 71-year-old female with primary biliary cirrhosis, multiple myeloma and hypothyroidism is reported. The liver biopsy showed stage II-III histologic damage according to Scheuer's classification and the multiple myeloma was IgG-lambda type, stage II-A at the time of diagnosis. Another three cases of primary biliary cirrhosis associated with multiple myeloma were found in the literature. As a group, the four cases had mild or moderate liver damage, extensive bone lesions and three of four cases had multiple myeloma IgG-lambda type. Although this association could be incidental, there is evidence that implies a pathogenic relationship. This information is summarized in this report.


Subject(s)
Hypothyroidism/complications , Liver Cirrhosis, Biliary/complications , Multiple Myeloma/complications , Aged , Cell Transformation, Neoplastic , Female , Humans , Hypergammaglobulinemia/etiology , Immunoglobulin M/blood , Immunoglobulin lambda-Chains/analysis , Liver Cirrhosis, Biliary/immunology , Lymphocyte Activation , Lymphocyte Subsets/immunology , Lymphocyte Subsets/pathology , Myeloma Proteins/analysis , Vitiligo/complications
7.
Scand J Gastroenterol Suppl ; 222: 49-52, 1997.
Article in English | MEDLINE | ID: mdl-9145447

ABSTRACT

Lactose intolerance occurs in the majority of human groups, excluding people from Northern Europe. Because its effect is similar to that of lactulose, lactose seems to be an alternative treatment for patients with portal-systemic encephalopathy (PSE) and lactase deficiency. The mechanism of action of lactose is similar to that of lactulose. In vivo, lactose improves PSE parameters and causes acidic diarrhea. We performed in vitro studies in a fecal incubation system to investigate the biochemical and bacteriological effects induced by different substances customarily used for the treatment of patients with PSE (lactose, lactulose and Neomycin). In vitro experiments showed that lactose and lactulose decreased aerobic flora counts and reduced the pH of fecal incubation. Both disaccharides reduced the ammonia concentration in the incubation system.


Subject(s)
Colon/microbiology , Gastrointestinal Agents/pharmacology , Hepatic Encephalopathy/drug therapy , Lactose Intolerance/complications , Lactose/pharmacology , Lactulose/pharmacology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Feces/microbiology , Fermentation , Gastrointestinal Agents/therapeutic use , Hepatic Encephalopathy/complications , Hepatic Encephalopathy/microbiology , Humans , In Vitro Techniques , Lactose/therapeutic use , Lactulose/therapeutic use , Neomycin/pharmacology , Neomycin/therapeutic use
10.
Rev Gastroenterol Mex ; 60(1): 31-44, 1995.
Article in Spanish | MEDLINE | ID: mdl-7638529

ABSTRACT

Diet may be modified and can alter the hepatic function or contributes to maintain it on excellent state. The objective of this paper was to review the recently advances on the clinical aspects of nutrition in chronic liver diseases and the underlying rationale for specific nutritional therapies focusing in the works in Mexico. Original papers in english and spanish informed on Medline until 1994 were included. We also review the national literature about nutrition aspects on liver diseases.


Subject(s)
Liver Diseases/diet therapy , Nutritional Physiological Phenomena , Chronic Disease , Energy Metabolism , Humans , Liver Diseases/metabolism , Minerals/administration & dosage , Nutrition Disorders/etiology , Nutritional Requirements , Trace Elements/administration & dosage , Vitamins/administration & dosage
11.
Rev Gastroenterol Mex ; 59(2): 147-56, 1994.
Article in Spanish | MEDLINE | ID: mdl-7991968

ABSTRACT

The role of gallbladder motility (GBM) in gastrointestinal diseases has been frequently ignored. Recently however, the introduction of new diagnostic methods and data on the normal physiology of gallbladder emptying and refilling have placed this interesting area of gastrointestinal motility where it justly deserves. In this way it has been possible to recognize and further study the pathophysiologic mechanisms involved in some clinical situations with a higher-than expected frequency of gallstones (GS). It has also been possible to identify with more clarity the role GBM has in the chain of events that lead to GS development and thus, to plan prevention or therapeutic strategies. The discovery of new drugs with effects on GBM have also permitted to further advance in the knowledge of normal physiologic mechanisms and to have access to possible future treatments. Also pathologic entities have been clearly defined, such as chronic acalculous cholecystitis. In this review we present recent knowledge on normal GBM physiology and its clinical applications as well consequences of its dysfunction.


Subject(s)
Cholecystitis/physiopathology , Cholelithiasis/physiopathology , Gallbladder/physiology , Cholecystitis/prevention & control , Cholecystitis/therapy , Cholelithiasis/prevention & control , Cholelithiasis/therapy , Chronic Disease , Female , Gallbladder/physiopathology , Humans , Male , Research
12.
Rev Gastroenterol Mex ; 58(2): 136-44, 1993.
Article in Spanish | MEDLINE | ID: mdl-7747024

ABSTRACT

We review the pathogenesis of cholesterol gallstones, which occur in five steps: 1) metabolic; 2) chemical; 3) nucleation, 4) growing and maturation of gallstones; 5) clinical. It is emphasized that in the third step it could occur an arenous precipitate formed by cholesterol crystals, calcium bilirrubinate granules, calcium phosphate, or fatty acids anions and calcium, and mucin, called "biliary sludge", which has been associated with cholecystitis and pancreatitis. We describe the gallbladder motor abnormalities that occur during the lithogenesis and the diagnostic approach through scintigraphy and real time ultrasound. We review the pancreatobiliary dyskinesia, a condition associated with the postcholecystectomy syndrome. This later condition can result from anatomic stenosis or dyskinetic dysfunction of the sphincter of Oddi. Likewise, it is pointed out that at the present time, the manometric evaluation of the sphincter of Oddi is the gold standard in the diagnostic approach of this condition.


Subject(s)
Bile Ducts/physiology , Gallbladder/physiology , Biliary Tract Diseases/diagnosis , Biliary Tract Diseases/physiopathology , Cholelithiasis/diagnosis , Cholelithiasis/physiopathology , Gallbladder Emptying , Humans , Reference Values
13.
Rev Gastroenterol Mex ; 57(3): 191-8, 1992.
Article in Spanish | MEDLINE | ID: mdl-1308300

ABSTRACT

The objectives of this survey were to evaluate the medical knowledge, acceptance and application of research results, and to identify the main sources of information in our environment. Portal-systemic encephalopathy (PSE) was the specific health problem addressed. Three hundred seventy-seven attendants to the National Mexican Gastroenterology Week (december 14-19, 1991) were surveyed. The results point out: 1) Gaps in PSE knowledge, since 30% or more incorrect answers were obtained for some PSE manifestations and therapeutic measures; 2) A persistent use of measures with doubtful efficacy, which is exemplified by the regular use of neomycin by (80%) of the respondents, 3) frequent influence of the availability of therapeutic measures (68%), as the satisfaction with therapeutic response (66%) on PSE treatment patterns, and 4) important role of continuing education courses and/or scientific meetings (> 66%) and medical journals (> 57%) as sources of information.


Subject(s)
Clinical Competence , Hepatic Encephalopathy/therapy , Surveys and Questionnaires , Adult , Aged , Humans , Middle Aged , Research
15.
Rev Invest Clin ; 42(3): 231-9, 1990.
Article in Spanish | MEDLINE | ID: mdl-2270372

ABSTRACT

Extracorporeal shock waves lithotripsy is a new procedure discovered and applied in the present decade to treat urinary and biliary stones. Shock waves are acoustic waves similar to sonic waves which follow the acoustic laws and therefore the shock waves can be refracted or reflected depending on the medium interface. Due to the high water content, the human body can be crossed by shock waves which eventually may be focused on the target stone. There are several commercially available shock waves generators, i.e. the spark gap emisors which were the first ones, and the piezoceramic and electromagnetic emisors. To focus the shock waves on a biliary stone the machines are provided with fluoroscopic or ultrasound devices or with both in the most advanced machines. Using an electromagnetic emisor (Lithostar plus) our group has treated 78 patients with biliary stones without analgesia or anesthesia. Total stone fragmentation was achieved in 85% of the cases. In patients with cholesterol gallstones who undergo lithotripsy, an adjuvant treatment with oral cholesterol solvent is mandatory. Extracorporeal biliary lithotripsy is free of mortality, and the morbidity is less than 5%.


Subject(s)
Cholelithiasis/therapy , Lithotripsy , Humans , Physical Phenomena , Physics
16.
Rev Invest Clin ; 42 Suppl: 48-52, 1990 Jul.
Article in Spanish | MEDLINE | ID: mdl-19256134

ABSTRACT

Prevalence of gallstone disease in autopsies from Mexico is 14.3%, 8.4% in men and 20.4% in women respectively. Frequency of cholelithiasis has increased remarkably from 12.2% in 1950 to 15.8% in 1980 (p < 0.05). Population of low socioeconomic status is apparently more affected. Obesity is the clinical association more frequently found in the population studied. Cholesterol gallstones showed the highest frequency. Economic cost of this disease is high. We conclude that gallstone disease is a public health problem for our country.


Subject(s)
Cholelithiasis/epidemiology , Adult , Aged , Aged, 80 and over , Cholelithiasis/economics , Cholelithiasis/metabolism , Comorbidity , Diet , Female , Gallstones/chemistry , Humans , Male , Mexico/epidemiology , Middle Aged , Obesity/epidemiology , Pregnancy , Pregnancy Complications/epidemiology , Prevalence , Risk Factors , Socioeconomic Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...